59 related articles for article (PubMed ID: 12404304)
1. The effect of the serotonergic system on opioid withdrawal-like syndrome in a mouse model of cholestasis.
Dehpour AR; Sadeghipour HR; Nowroozi A; Akbarloo N
Hum Psychopharmacol; 2000 Aug; 15(6):423-428. PubMed ID: 12404304
[TBL] [Abstract][Full Text] [Related]
2. Effect of NMDA receptor antagonist on naloxone-precipitated withdrawal signs in cholestatic mice.
Dehpour AR; Samini M; Rastegar H; Ardeshiri AJ; Roushanzamir F; Jorjani M; Ahmadiani A
Hum Psychopharmacol; 2000 Apr; 15(3):213-218. PubMed ID: 12404334
[TBL] [Abstract][Full Text] [Related]
3. Endogenous nitric oxide modulates naloxone-precipitated withdrawal signs in a mouse model with acute cholestasis.
Dehpour AR; Akbarloo N; Ghafourifar P
Behav Pharmacol; 1998 Feb; 9(1):77-80. PubMed ID: 9832951
[TBL] [Abstract][Full Text] [Related]
4. Comparison of simultaneous administration of lithium with L-NAME or L-arginine on morphine withdrawal syndrome in mice.
Dehpour AR; Sadr SS; Nouroddini M; Shadan F; Nourozi A; Farahani M; Sahebgharani M
Hum Psychopharmacol; 2000 Mar; 15(2):87-93. PubMed ID: 12404337
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
[TBL] [Abstract][Full Text] [Related]
7. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
Hasanein P; Shahidi S; Komaki A; Mirazi N
Eur J Pharmacol; 2008 Sep; 591(1-3):132-5. PubMed ID: 18593578
[TBL] [Abstract][Full Text] [Related]
8. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
9. A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis.
Hasanein P; Javanmardi K
Fundam Clin Pharmacol; 2008 Oct; 22(5):517-22. PubMed ID: 18844724
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of levodopa and bromocriptine on naloxone-precipitated morphine withdrawal symptoms in mice.
Samini M; Fakhrian R; Mohagheghi M; Dehpour AR
Hum Psychopharmacol; 2000 Mar; 15(2):95-101. PubMed ID: 12404338
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
Trang T; Koblic P; Kawaja M; Jhamandas K
Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
[TBL] [Abstract][Full Text] [Related]
12. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
13. Obstructive cholestasis alters intestinal transit in mice: role of opioid system.
Ghaffari K; Savadkuhi ST; Honar H; Riazi K; Shafaroodi H; Moezi L; Ebrahimkhani MR; Tahmasebi MS; Dehpour AR
Life Sci; 2004 Dec; 76(4):397-406. PubMed ID: 15530502
[TBL] [Abstract][Full Text] [Related]
14. Mianserin and trazodone significantly attenuate the intensity of opioid withdrawal symptoms in mice.
Schreiber S; Backler MM; Herman I; Shamir D; Rigai T; Bar-Hamburger R; Pick CG
Addict Biol; 2003 Mar; 8(1):107-14. PubMed ID: 12749364
[TBL] [Abstract][Full Text] [Related]
15. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
16. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
17. The involvement of alpha 2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in mice.
Ozdogan UK; Lähdesmäki J; Hakala K; Scheinin M
Eur J Pharmacol; 2004 Aug; 497(2):161-71. PubMed ID: 15306201
[TBL] [Abstract][Full Text] [Related]
18. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
19. Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice.
Kambur O; Männistö PT; Viljakka K; Reenilä I; Lemberg K; Kontinen VK; Karayiorgou M; Gogos JA; Kalso E
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):367-73. PubMed ID: 18834357
[TBL] [Abstract][Full Text] [Related]
20. Possible involvement of the opioidergic system in the modulation of body temperature, jumping behavior and memory process in cholestatic and addicted mice.
Zarrindast MR; Issazadeh Y; Rezaei N; Khakpai F
EXCLI J; 2020; 19():311-322. PubMed ID: 32256271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
